Quantcast Who's Who in Celiac Disease Drug Development | NFCA
Skip Navigation Links

Who's Who in Celiac Disease Drug Development

Updates from Pharmaceutical and Biotechnology Companies in the Celiac Disease Field

Researchers around the world are working to develop alternative treatments for celiac disease. These treatments may revolutionize the way we think about celiac disease – and you can start learning about them now.

New Treatment Options

Who's Who:

Alba Pharmaceuticals logo
Alba Therapeutics


Alvine Pharmaceuticals logoAlvine Pharmaceuticals


  • Drug in development: ALV003 (adjunct treatment, a mixture of two gluten-specific recombinant proteases)
  • www.alvinepharma.com

BiolineRX logoBiolineRX


  • Drug in development: BL-7010 (novel, high molecular weight, non-absorbable, orally available polymer)
  • www.biolinerx.com

Calypso Biotech logoCalypso Biotech


Celimmune Logo

Celimmune, LLC


  • Drug in development: AMG 714 (fully human immunoglobulin monoclonal antibody)
  • www.celiumme.com

Cour Pharmaceuticals logoCour Pharmaceuticals


  • Drug in development: COUR-NP-GLI (Toleragenic Immune Modifying nanoParticles)
  • www.courpharma.com

Dr Falk logoDoctor Falk Pharmaceuticals


  • Drug in development: ZED1227 (direct acting inhibitor of tissue transglutaminase)
  • www.drfalk.co.uk

ImmusanT logoImmusanT


Institute for Protein Design LogoInstitute for Protein Design


Sitari logoSitari


Diagnosis Tools

Biomedal logoBioMedal


Additional Resources:

Drug Information Association (DIA) Press Release
NFCA’s Healthcare Relations Manager Kristin Voorhees is a member of the Class of 2013 Patient Advocate Fellows for the DIA. DIA is a neutral, global, professional and member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related health-care products.

Playing a Role in Research: Celiac Disease Drug Development and the Drug Information Association
As people living with celiac disease, we play a role in clinical research and the drug development process.  This very topic was discussed at a recent conference attended by NFCA's Healthcare Relations Manager Kristin Voorhees.  In this staff blog post, she recounts her experience at the Drug Information Association (DIA) 49th Annual Meeting as a 2013 DIA Patient Advocate Fellow.


Share your feedback!

This webpage...


  • Have you or your family members been diagnosed?
    Complete our celiac disease symptoms checklist today to find out if you are at risk of having celiac disease or non-celiac gluten sensitivity ('gluten sensitivity').  We can help improve your quality of life!
  • Stay Informed!
    Join our monthly newsletter to receive news, updates, and tips for healthy gluten-free living and information about celiac disease. Sign-up for the monthly e-mail newsletter